Sterling Capital Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
PCM
MWM
MNBTD
LSERS
SOADOR
PFSRSONJ
Sterling Capital Management's NEO Position: Q2 2026 in Review
Sterling Capital Management reduced its NeoGenomics (NEO) stake by 38% in Q2 2026, selling an estimated $14.4K and leaving 2,455 shares worth $35.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1669.
Sterling Capital Management first reported a position in NEO in Q3 2024 and has held it in 8 quarters since. The position peaked at $80.1K in Q4 2025. 57 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Sterling Capital Management held 2,455 shares of NeoGenomics worth $35.8K as of Q2 2026.
- Sterling Capital Management sold 1,492 NeoGenomics shares in Q2 2026, an estimated $14.4K.
- NeoGenomics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1669 holding.
- Sterling Capital Management first reported a position in NeoGenomics in Q3 2024 and has held it in 8 quarters since.
- Sterling Capital Management's NeoGenomics position peaked at $80.1K in Q4 2025.
- 57 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.